Definition and global epidemiology of pediatric acute respiratory distress syndrome

Fernando Beltramo1, Robinder G Khemani1

  • 1Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.

Insights

The 2015 Pediatric Acute Lung Injury Consensus Conference (PALICC) definition for pediatric ARDS (PARDS) reflects current practice, but severity alone doesn't predict outcomes. Continued research is needed for better risk stratification in pediatric ARDS.

Area of Science:

  • Pediatric critical care medicine
  • Respiratory medicine
  • Pediatric pulmonology

Background:

  • Pediatric Acute Respiratory Distress Syndrome (PARDS) has evolved since initial descriptions.
  • The 2015 Pediatric Acute Lung Injury Consensus Conference (PALICC) established specific diagnostic criteria for PARDS.
  • Key changes included simplified radiography, pulse oximetry, non-invasive ventilation criteria, and oxygenation index (OI) use.

Purpose of the Study:

  • To evaluate the impact of the 2015 PALICC definition on PARDS epidemiology.
  • To assess the correlation between PARDS severity and clinical outcomes.
  • To determine if the new definition aligns with current clinical practices.

Main Methods:

  • Literature review of studies published after the 2015 PALICC definition.
  • Analysis of epidemiological trends in pediatric ARDS.
  • Assessment of the relationship between PARDS severity metrics and patient outcomes.

Main Results:

  • Despite definition changes, core epidemiological elements of PARDS have remained stable over two decades.
  • The PALICC definition appears to align with contemporary clinical practices.
  • PARDS severity, as defined by PALICC, is insufficient for predicting mortality and other outcomes, though severe hypoxemia shows some association.

Conclusions:

  • The 2015 PALICC definition for PARDS is a valuable tool reflecting current practice.
  • Further research is necessary to refine outcome prediction beyond current severity metrics.
  • Improved risk stratification models are needed for pediatric ARDS patients.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
961
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
473
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
765
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
397
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
695
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.9K